DAVITA INC. Proceeds from Sale and Maturity of Held-to-maturity Securities
DAVITA INC. (DVA) reported Proceeds from Sale and Maturity of Held-to-maturity Securities of $942.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities · last filed 2026-08-04
- DAVITA INC. proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- DAVITA INC. proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2026-03-31 was $942.00K, a 69.42% decline year-over-year.
- DAVITA INC. proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2025-12-31 was $7.36M, a 1248.35% increase year-over-year.
- DAVITA INC. proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2025-09-30 was -$9.96M, a 166.38% decline year-over-year.
- DAVITA INC. proceeds from sale and maturity of held-to-maturity securities for fiscal 2025 was $45.41M, a 100.61% increase from fiscal 2024.
- DAVITA INC. proceeds from sale and maturity of held-to-maturity securities for fiscal 2024 was $22.64M, a 77.28% decline from fiscal 2023.
- DAVITA INC. proceeds from sale and maturity of held-to-maturity securities for fiscal 2023 was $99.64M, a 40.09% increase from fiscal 2022.
- DAVITA INC. proceeds from sale and maturity of held-to-maturity securities for fiscal 2022 was $71.13M, a 348.77% increase from fiscal 2021.
| Period end | Proceeds from Sale and Maturity of Held-to-maturity Securities 3 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 6 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 9 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $942.00K 10-Q · filed 2026-08-04 | $8.30M derived: sum of 3 quarters · filed 2026-08-04 | -$1.66M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $942.00K 10-Q · filed 2026-05-05 | $8.30M derived: sum of 2 quarters · filed 2026-05-05 | -$1.66M derived: sum of 3 quarters · filed 2026-05-05 | $43.27M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $7.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$2.60M derived: sum of 2 quarters · filed 2026-02-11 | $42.33M derived: sum of 3 quarters · filed 2026-08-04 | $45.41M 10-K · filed 2026-02-11 |
| 2025-09-30 | -$9.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $34.97M derived: sum of 2 quarters · filed 2026-08-04 | $38.05M 10-Q · filed 2025-10-29 | $38.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $44.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $48.01M 10-Q · filed 2026-08-04 | $48.56M derived: sum of 3 quarters · filed 2026-08-04 | $63.57M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $3.08M 10-Q · filed 2026-05-05 | $3.63M derived: sum of 2 quarters · filed 2026-05-05 | $18.64M derived: sum of 3 quarters · filed 2026-05-05 | $25.42M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $546.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $15.56M derived: sum of 2 quarters · filed 2026-02-11 | $22.34M derived: sum of 3 quarters · filed 2026-02-11 | $22.64M 10-K · filed 2026-02-11 |
| 2024-09-30 | $15.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $21.79M derived: sum of 2 quarters · filed 2025-10-29 | $22.09M 10-Q · filed 2025-10-29 | $27.32M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $6.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $7.08M 10-Q · filed 2025-08-05 | $12.31M derived: sum of 3 quarters · filed 2026-02-11 | $12.31M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-12 | $5.53M derived: sum of 2 quarters · filed 2026-02-11 | $5.53M derived: sum of 3 quarters · filed 2026-02-11 | $49.68M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $5.22M derived: sum of 2 quarters · filed 2026-02-11 | $49.38M derived: sum of 3 quarters · filed 2026-02-11 | $99.64M 10-K · filed 2026-02-11 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $44.16M derived: sum of 2 quarters · filed 2024-10-29 | $94.41M 10-Q · filed 2024-10-29 | $124.88M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $44.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $94.41M 10-Q · filed 2024-08-06 | $124.88M derived: sum of 3 quarters · filed 2025-02-13 | $157.12M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $50.26M 10-Q · filed 2024-05-02 | $80.72M derived: sum of 2 quarters · filed 2025-02-13 | $112.97M derived: sum of 3 quarters · filed 2025-02-13 | $116.31M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $30.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $62.71M derived: sum of 2 quarters · filed 2025-02-13 | $66.06M derived: sum of 3 quarters · filed 2025-02-13 | $71.13M 10-K · filed 2025-02-13 |
| 2022-09-30 | $32.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $35.59M derived: sum of 2 quarters · filed 2023-11-07 | $40.66M 10-Q · filed 2023-11-07 | $43.23M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $8.41M 10-Q · filed 2023-08-03 | $10.99M derived: sum of 3 quarters · filed 2024-02-14 | $16.34M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $5.07M 10-Q · filed 2023-05-08 | $7.64M derived: sum of 2 quarters · filed 2024-02-14 | $13.00M derived: sum of 3 quarters · filed 2024-02-14 | $15.57M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $7.93M derived: sum of 2 quarters · filed 2024-02-14 | $10.50M derived: sum of 3 quarters · filed 2024-02-14 | $15.85M 10-K · filed 2024-02-14 |
| 2021-09-30 | $5.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31 | $7.92M derived: sum of 2 quarters · filed 2022-10-31 | $13.27M 10-Q · filed 2022-10-31 | $16.15M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $7.92M 10-Q · filed 2022-08-01 | $10.79M derived: sum of 3 quarters · filed 2023-02-22 | $151.51M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $5.35M 10-Q · filed 2022-05-05 | $8.22M derived: sum of 2 quarters · filed 2023-02-22 | $148.94M derived: sum of 3 quarters · filed 2023-02-22 | $151.51M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $143.59M derived: sum of 2 quarters · filed 2023-02-22 | $146.16M derived: sum of 3 quarters · filed 2023-02-22 | $151.21M 10-K · filed 2023-02-22 |
| 2020-09-30 | $140.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $143.29M derived: sum of 2 quarters · filed 2021-10-28 | $148.34M 10-Q · filed 2021-10-28 | $243.72M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $7.62M 10-Q · filed 2021-08-03 | $103.00M derived: sum of 3 quarters · filed 2022-02-11 | $103.00M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $5.05M 10-Q · filed 2021-04-29 | $100.42M derived: sum of 2 quarters · filed 2022-02-11 | $100.42M derived: sum of 3 quarters · filed 2022-02-11 | $100.42M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $95.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $95.38M derived: sum of 2 quarters · filed 2022-02-11 | $95.38M derived: sum of 3 quarters · filed 2022-02-11 | $95.38M 10-K · filed 2022-02-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | $2.23M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | $2.23M derived: sum of 3 quarters · filed 2021-02-12 | $2.23M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-05 | $2.23M derived: sum of 2 quarters · filed 2021-02-12 | $2.23M derived: sum of 3 quarters · filed 2021-02-12 | $3.41M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $2.23M derived: sum of 2 quarters · filed 2021-02-12 | $3.41M derived: sum of 3 quarters · filed 2021-02-12 | $34.86M 10-K · filed 2021-02-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.17M derived: sum of 2 quarters · filed 2019-11-07 | $32.63M 10-Q · filed 2019-11-07 | $126.33M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $32.63M 10-Q · filed 2019-08-02 | $126.33M derived: sum of 3 quarters · filed 2020-02-21 | $204.61M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $31.45M 10-Q · filed 2019-05-07 | $125.16M derived: sum of 2 quarters · filed 2020-02-21 | $203.44M derived: sum of 3 quarters · filed 2020-02-21 | $407.64M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $93.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $171.99M derived: sum of 2 quarters · filed 2020-02-21 | $376.19M derived: sum of 3 quarters · filed 2020-02-21 | $492.47M 10-K · filed 2020-02-21 |
| 2017-09-30 | $78.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $282.48M derived: sum of 2 quarters · filed 2018-11-07 | $398.76M 10-Q · filed 2018-11-07 | $895.33M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $204.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $320.48M 10-Q · filed 2018-08-01 | $817.04M derived: sum of 3 quarters · filed 2019-02-22 | $1.02B derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | $116.28M 10-Q · filed 2018-05-03 | $612.85M derived: sum of 2 quarters · filed 2019-02-22 | $811.10M derived: sum of 3 quarters · filed 2019-02-22 | $1.10B derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $496.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $694.82M derived: sum of 2 quarters · filed 2019-02-22 | $987.80M derived: sum of 3 quarters · filed 2019-02-22 | $1.24B 10-K · filed 2019-02-22 |
| 2016-09-30 | $198.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $491.24M derived: sum of 2 quarters · filed 2017-11-07 | $743.94M 10-Q · filed 2017-11-07 | $1.41B derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $292.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $545.68M 10-Q · filed 2017-08-01 | $1.21B derived: sum of 3 quarters · filed 2018-02-23 | $1.75B derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $252.70M 10-Q · filed 2017-05-02 | $920.51M derived: sum of 2 quarters · filed 2018-02-23 | $1.46B derived: sum of 3 quarters · filed 2018-02-23 | $1.68B derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $667.81M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $1.20B derived: sum of 2 quarters · filed 2018-02-23 | $1.43B derived: sum of 3 quarters · filed 2018-02-23 | $1.64B 10-K · filed 2018-02-23 |
| 2015-09-30 | $534.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $763.90M derived: sum of 2 quarters · filed 2016-11-02 | $969.55M 10-Q · filed 2016-11-02 | $1.08B derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $229.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $434.68M 10-Q · filed 2016-08-08 | $547.98M derived: sum of 3 quarters · filed 2017-02-24 | $511.19M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $205.65M 10-Q · filed 2016-05-04 | $318.94M derived: sum of 2 quarters · filed 2017-02-24 | $282.16M derived: sum of 3 quarters · filed 2017-02-24 | $345.21M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $113.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $76.51M derived: sum of 2 quarters · filed 2017-02-24 | $139.56M derived: sum of 3 quarters · filed 2017-02-24 | $141.07M 10-K · filed 2017-02-24 |
| 2014-09-30 | -$36.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $26.27M derived: sum of 2 quarters · filed 2015-11-05 | $27.78M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $63.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $64.56M 10-Q · filed 2015-08-05 | ||
| 2014-03-31 | $1.51M 10-Q · filed 2015-05-05 | |||
| 2013-12-31 | $1.38M 10-K · filed 2016-02-26 | |||
| 2012-12-31 | $14.53M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |